BSEBoard Meeting10 Aug 2026 · 10 Aug 2026, 04:23 pm
Outcome of Board Meeting
Gland Pharma Ltd · 543245
✦ AI SummaryResults
Gland Pharma Ltd's board meeting outcome for unaudited financial results for the quarter ended June 30, 2026, has been approved with the company's results being prepared in compliance with Indian Accounting Standards. The board meeting was held on August 11, 2026, and the unaudited financial results for the quarter ended June 30, 2026, have been prepared in accordance with the Listing Obligations and Disclosure Requirements of the Securities and Exchange Board of India.
Analysis Scores
Earnings Impact8/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk3/10
Balance Sheet Risk6/10
Liquidity Impact9/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Gland Pharma Ltd - 543245 - Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended June 30, 2026